111-58-0
Chemical Structure
Oleoylethanolamide
Synonym(s): N-Oleoylethanolamide; Oleamide MEA; Oleic acid monoethanolamide
- CAS No.: 111-58-0
- Formula:C20H39NO2
- Molecular Weight:325.53
IUPAC Name: N-(2-hydroxyethyl)oleamide
InChIKey: BOWVQLFMWHZBEF-KTKRTIGZSA-N
SMILES: CCCCCCCC/C=C\CCCCCCCC(NCCO)=O
Biological Activity: Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oleoylethanolamide | 98.19% | Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oleoylethanolamide (Standard) | 99.86% | Oleoylethanolamide (Standard) is the analytical standard of Oleoylethanolamide. This product is intended for research and analytical applications. Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oleoylethanolamide-d2 | Oleoylethanolamide-d2 is the deuterium labeled Oleoylethanolamide. Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oleoylethanolamide-d4 | Oleoylethanolamide-d4 is the deuterium labeled Oleoylethanolamide. Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MMP-2 Inhibitor I | 99.24% | MMP-2 Inhibitor I (OA-Hy) is a potent MMP-2 inhibitor with a Ki of 1.7 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Oleoyl glycine (Standard) | ≥98% | N-Oleoyl glycine (Standard) is the analytical standard of N-Oleoyl glycine (HY-113204). This product is intended for research and analytical applications. N-Oleoyl glycine is a lipoamino acid, which stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Linoleoyl ethanolamide | 99.98% | Linoleoyl ethanolamide (Linoleic acid monoethanolamide) is classified as a fatty acid ethanolamide. Linoleoyl ethanolamide only weakly binds G-protein-coupled cannabinoid receptors of type-1(CB1)and CB2 receptors, and inhibits the binding of [3H]CP-55,940 with Kis of 10 and 25 μM, respectively. Linoleoyl ethanolamide is 4-fold less potent than anandamide at causing catalepsy in mice and it does not prolong sleep time. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Linoleoyl ethanolamide-d4 | 99.15% | Linoleoyl ethanolamide-d4 is a deuterated labeled Linoleoyl ethanolamide. Linoleoyl ethanolamide (Linoleic acid monoethanolamide) is classified as a fatty acid ethanolamide. Linoleoyl ethanolamide only weakly binds G-protein-coupled cannabinoid receptors of type-1(CB1)and CB2 receptors, and inhibits the binding of [3H]CP-55,940 with Kis of 10 and 25 μM, respectively. Linoleoyl ethanolamide is 4-fold less potent than anandamide at causing catalepsy in mice and it does not prolong sleep time. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oleoyl ethyl amide | 99.9% | Oleoyl ethyl amide (N-Ethyloleamide) is a fatty acid amide hydrolase (FAAH) inhibitor that can cross the blood-brain barrier. Oleoyl ethyl amide enhances endogenous cannabinoid signaling by inhibiting FAAH, and via CB1/CB2 and TRPV1 receptor mediation, thereby modulating peripheral sensory and motor nerve transmission. Oleoyl ethyl amide can be used in research on overactive bladder and premature ejaculation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoleoyl ethanolamide | 99.77% | Palmitoleoyl ethanolamide (POEA) is an endogenous fatty amide with biological activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
AM3102 | 98.0% | AM3102 is an oleoylethanolamide (OEA) analog. AM3102 is an endogenous high-affinity PPAR-alpha agonist. AM3102 resists enzymatic hydrolysis, activates PPAR-alpha with high potency in vitro, and persistently reduces feeding when administered in vivo either parenterally or orally. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Linolenoylethanolamine-d4 | N-Linolenoylethanolamine-d4 is the deuterium labeled N-Linolenoylethanolamine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Docosaenoyl ethanolamide | Docosaenoyl ethanolamide (N-(2-Hydroxyethyl)-13Z-docosenamide) is one of a fatty N-acyl ethanolamines. Ethanolamines can be detected at relatively high levels in rat cerebrospinal fluid. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(9Z,11E)-Octadecadien ethanolamide | (9Z,11E)-Octadecadien ethanolamide is an ester product. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
11(Z),14(Z)-Eicosadienoic acid ethanolamide | 11(Z),14(Z)-Eicosadienoic acid ethanolamide (Compound 3) is an ethanolamide-conjugated form of 11(Z),14(Z)-Eicosadienoic acid (HY-149589). 11(Z),14(Z)-Eicosadienoic acid ethanolamide inhibits the inactivating transport of an endogenous cannabinoid substance with an IC50 value of 10.6 μM. 11(Z),14(Z)-Eicosadienoic acid ethanolamide can be used for research of neuropsychiatric conditions. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
C17:1 Anandamide | C17:1 Anandamide is an anandamide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
C18:1 Anandamide | C18:1 Anandamide is an anandamide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Palmitoylethanolamide-d4-1 | Palmitoylethanolamide-d4-1 is a deuterated labeled Palmitoylethanolamide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||